Euro-Global Summit on Advances in Structural Biology and Protein Chemistry

Scope & Importance

There are several reasons why someone should attend an Internal Conference on Structural Biology and Biochemistry:

Networking Opportunities: Attending a conference provides an opportunity to network with other researchers, professionals, and experts in the field of structural biology and biochemistry. These networking opportunities can lead to collaborations, job opportunities, and future research collaborations.

Stay Updated on the Latest Research: Conferences provide a platform to learn about the latest research and advancements in the field of structural biology and biochemistry. Attendees can attend presentations and talks by leading experts in the field, which can help them stay up-to-date on the latest findings and trends.

Share Your Research: Conferences also provide an opportunity to present your own research and get feedback from peers and experts in the field. This can help you refine your research and improve its impact.

Professional Development: Conferences often include workshops and training sessions that can help attendees develop their skills and knowledge in the field of structural biology and biochemistry. These sessions can provide valuable training in specialized techniques and tools that can be applied to research.

Exposure to New Ideas: Conferences bring together researchers from different backgrounds and disciplines, which can lead to exposure to new ideas and approaches. This can help attendees develop new insights and perspectives on their own research and the field as a whole.

Market Insights of Structural Biology in USA:

The market value of Structural Biology in the USA is significant, as the country is home to some of the leading research institutions, pharmaceutical companies, and biotechnology firms in this field. According to a report by ResearchAndMarkets, the structural biology market in the USA was valued at USD 591.7 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.7% during the forecast period of 2021-2028.

The growth of the market in the USA is driven by factors such as the increasing prevalence of chronic diseases, rising demand for personalized medicine, and the growing adoption of structural biology techniques in drug discovery and development. In addition, the availability of government funding for research in this field is also contributing to the growth of the market.

The USA is home to some of the world's leading research institutions and universities, such as the National Institutes of Health (NIH), Harvard University, Stanford University, and the University of California, San Francisco (UCSF), among others. These institutions are conducting cutting-edge research in the field of Structural Biology, leading to new discoveries and breakthroughs in drug discovery and development.

Overall, the market value of Structural Biology in the USA is expected to continue to grow in the coming years, driven by factors such as technological advancements, increasing government funding, and rising demand for personalized medicine.

Market Insights of Structural Biology in Europe:

Structural Biology is a growing field in Europe, and it is contributing significantly to the region's research and innovation activities. According to a report by Allied Market Research, the European structural biology and molecular modeling market was valued at USD 839.45 million in 2020 and is projected to reach USD 1.21 billion by 2028, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period.

The growth of the market is driven by factors such as the increasing demand for new drug development, growing adoption of structural biology techniques in the biopharmaceutical industry, and advancements in technology. The region has a robust infrastructure for research and development, which is supporting the growth of the structural biology market.

The European Union is also actively investing in research and development activities related to structural biology through various initiatives and funding programs. For instance, the Horizon 2020 program has funded several projects related to structural biology and molecular modeling, with a focus on developing new therapies for a range of diseases.

In addition, many research institutions, academic centers, and biopharmaceutical companies are collaborating to develop new technologies and tools for structural biology research in Europe. This is leading to new discoveries and breakthroughs in the field, and is expected to further drive the growth of the market in the coming years.

Overall, the market value of Structural Biology in Europe is expected to continue to grow, driven by advancements in technology, increasing investment in research and development activities, and growing demand for new drug development in the biopharmaceutical industry.